Takami Sato, MD
Professor, Medical Oncology

Contact Dr. Sato

111 S. 11th Street
Suite 4240
Philadelphia, PA 19107

(215) 955-8874

Education
Education

University Appointment
Professor
Medical Oncology
Thomas Jefferson University

Research and Clinical Interests
My research interests are centered around the PI in phase III hapten-modified melanoma cell vaccine clinical trial and the PI for randomized phase II trial for immunoembolization with GM-CSF. Membership in the Vaccine Center would facilitate collaborative research with investigators on campus.

Publications

1. Transhepatic therapies for metastatic uveal melanoma
2. Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma
3. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
4. Pseudo-spherical evolutes of curves on a spacelike surface in three dimensional Lorentz-Minkowski space
5. Uveal melanoma trapped in the temple of doom
6. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
7. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
8. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
9. Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
10. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: A pilot study
11. Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
12. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
13. Conjunctival melanoma: Bladder and upper urinary tract metastases
14. Mind the BAP
15. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
16. Summary and assessment
17. A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma
18. Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular disease: Are there safe and potentially effective treatments?
19. Locoregional Management of Hepatic Metastasis From Primary Uveal Melanoma
20. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential

(This list reflects the most recent 20 publications)